Our Line-up
Dato' Ooi Sang Kuang
Chairman
Dato' Ooi Sang Kuang was appointed the Chairman of the Board for Xeraya Capital Sdn. Bhd. and Xeraya Capital Labuan Ltd. as of March 2013.

Dato' Ooi is highly regarded in the financial sector having held a number of senior management responsibilities in numerous reputable banks, fund management and financial services companies.

Dato' Ooi is the Chairman of OCBC Bank after being on the Board of OCBC Bank since February 2012 and appointed the non-executive lead independent director of the main Board since October 2013. He is also the Chairman of Cagamas (National Mortgage Corporation, Malaysia) Holdings Bhd., and its subsidiaries. He also serves on the Board of several companies. Dato' Ooi is a Fellow Member of the Institute of Bankers Malaysia.

Dato' Ooi began his career in Bank Negara Malaysia (BNM). He was attached to the Economics Department of BNM in 1971 and from there onwards, held various positions in the department before he left to join the private sector in 1984. Between 1984 and 2002, Dato' Ooi held various senior responsibilities in the financial services sector. He was Chief Economist, Asia Pacific, of Standard Chartered Bank, Singapore; Managing Director of Warburg Asset Management Pte. Ltd., Singapore; Regional Research Director of RHB Research Institute, a Director on the Board of RHB Bhd., RHB Investment Bank and Deputy Chairman of RHB Asset Management.

Between 2002 and June, 2010, Dato' Ooi was a Deputy Governor and a member on the Board of Directors of Bank Negara Malaysia (BNM). He was a member of the Monetary Policy Committee, Reserves Management Committee, Financial Stability Committee and Risk Management Committee. As Deputy Governor, Dato' Ooi was responsible for the Economic and Monetary Assessment; Reserves Management and Monetary Operations; and Operational Support sectors. From July 2010 to December 2011, he was appointed Special Advisor in BNM and led a Task Force to craft the Malaysian Financial Sector Blueprint, 2011-2020.

Dato' Ooi graduated with a Bachelor of Economics (Hons) degree in Applied Economics from University of Malaya in 1971 and holds a Master of Arts (Development Finance) from Boston University, USA.
Tengku Dato' Sri Azmil
Tengku Azmil is Khazanah's Executive Director for Investments and was appointed the first Chairman of the Board of Directors for Xeraya Capital from December 2011 until March 2013. In his tenure as Chairman, Tengku Azmil had overseen the development of Xeraya's hard and soft infrastructure and was responsible in building the firm towards a solid foundation.

Prior to Khazanah, from August 2009 to September 2011, Tengku Azmil was Managing Director and Chief Executive Officer of Malaysia Airlines. Before that, he was the Chief Financial Officer at Malaysian Airline System from December 2006 to August 2009. He also served as Managing Director/Chief Executive Officer of Penerbangan Malaysia Berhad (PMB).

Previously, he worked in the London and Hong Kong offices of PricewaterhouseCoopers. While at PricewaterhouseCoopers, Tengku specialised in the banking and capital markets sector, working on capital markets transactions and providing advice on operational and regulatory risk and structured and derivative transactions.

He is a graduate of the University of Cambridge, is a Chartered Accountant, an associate member of the Malaysian Institute of Accountants and the Institute of Chartered Accountants in England and Wales, and also an associate of the Association of Corporate Treasurers, United Kingdom.

Tengku graduated from the University of Cambridge with double first class honours in Economics.
Yeoh Keat Seng
Yeoh Keat Seng is a Fund Manager in Kumpulan Sentiasa Cemerlang Sdn Bhd. Previously, he was the Head of Private Client Services Division of CIMB and served in other parts of the BCHB Group, including as the Chief Executive Officer of Commerce Trust Berhad from 2001 and the Chief Executive Officer and Chief Investment Officer of Commerce Asset Fund Managers Sdn Bhd.

Keat Seng is presently a member of Malaysian Technology Development Corporation's (MTDC) Board and sits on various MTDC Board sub-committees. He is also Khazanah's Nominee Director in Malaysian Life Sciences Capital Fund (MLSCF), a US$160 million fund of which Xeraya is a co-manager.

Before joining the Commerce Group, he served as Head of Research for Crosby Securities (Malaysia) and Head of Research for Merrill Lynch (Malaysia). Besides being an analyst, he had also authored the book "Investing Your Savings," which was on the best-seller list in 2003 and 2004.

He holds a Degree in Accountancy from the National University Singapore and is also a CFA charterholder.
Prof. Dr. Zainul Fadziruddin bin Zainuddin
Prof. Zainul is currently Director of Advisory, Incubation and Nurturing at the Malaysian Technology Development Corporation. He was previously the Director of Innovation Office of University Science Malaysia, where he worked toward developing an internal innovation ecosystem to support discovery, creativity, collaboration, intellectual property creation and commercialization of research output of USM. From 1994-1999, he served as the Head, Medical Microbiology & Parasitology Department in the School of Medical Sciences. From 1999-2007, he was founding Dean of the School of Health Sciences.

In addition to an academic career, Prof. Zainul was an MTDC Board member from 2004 until early 2012 and chaired the Investment Committee of MTDC, which has seen close to 500 deal opportunities since 2006. He also gained deep industrial experience as a Senior Vice President in the Malaysian Biotechnology Corporation (BiotechCorp) in 2006, as well as serving on the boards of BiotechCorp, InnovationXchange Malaysia and Sanggar Sains.

Prof. Zainul holds a Bachelor of Science in Microbiology from University of East Anglia, United Kingdom and a Ph.D. in Molecular Microbiology from University of Surrey, United Kingdom.
Nik Rizal Kamil
Nik Rizal joined Xeraya's Board as a Board member in December 2013. He is presently a Director, Investments Division in Khazanah Nasional.

His professional career includes audit experience in Coopers & Lybrand, United Kingdom and Arthur Anderson &Co, KL, M&As and IPO work in RHB Sakura Merchant Bankers Bhd. He joined Sarawak Shell Berhad, Miri thereafter and was involved in business planning and operations for Shell Malaysia E&P, Shell Exploration and Production International Limited, Singapore and Shell Deepwater Borneo. He then assumed a senior finance role in Shell's London office. Prior to joining Khazanah, Nik Rizal was with Special Projects, Shell Malaysia.

Nik Rizal holds an MSc Finance from London Business School and a BSc (Hons) Economics and Accounting from University of Bristol, United Kingdom. He is also an Associate Chartered Accountant (ACA) with the Institute of Chartered Accountants England and Wales (ICAEW).
Fares Zahir
CEO
Fares Zahir was appointed Chief Executive Officer (“CEO”) of Xeraya Capital Sdn Bhd in January 2012. He has 20 years of experience in the field of investments in public and private equities. Fares was previously with Khazanah Nasional Bhd, where he headed the Life Sciences Unit that formulates investment strategies, and undertakes and monitors the organization's Life Sciences investments, and also headed Khazanah's Research Unit that undertakes research work in the areas of financial capital markets, industrial organization and economics.

Fares co-founded Xeraya Capital during his tenure in Khazanah together with other team members who collectively provided key input to the Government of Malaysia on incentivizing the Malaysian private sector to invest in risk capital.

Fares has been Co-Chairman of the Malaysian Life Sciences Capital Fund (“MLSCF”) since July 2008, a fund that is globally recognized in the biogreentech space. He has been a Board member of the Malaysian Technology Development Corporation (“MTDC”) and Spring Hill Bioventures from October 2005 and March 2008 respectively, and was appointed to the Board of the Malaysian Biotechnology Corporation (“Biotech Corp”) in December 2011. In addition, he sits on the Board of investee companies in the US, Germany and in Malaysia.

From 1999 to 2005, Fares was Director, Investment Research at UBS Investment Bank where he was a key member of their top rated Malaysian equity research team. From 1996 to 1999, he was Fund Manager with the Schroder Group (also a JV company of the PNB Group) where he managed the Schroder Group's institutional clients' portfolios after serving as an investment analyst from 1994-1996 making investment recommendations to the Schroder Group's portfolio managers worldwide. Fares started his career in Malaysia in the actuarial department of American International Assurance Co. Ltd. in Kuala Lumpur where he worked from 1992 to 1994.

Fares holds a Bachelor of Economics degree in Actuarial Studies from Macquarie University in Australia where he graduated in 1990 and a Master of Applied Science in Operations Research from University Technology Sydney in 1992. He is also a Chartered Financial Analyst (“CFA”) and an Associate of the Society of Actuaries (“ASA”) of North America.
Fares Zahir
CEO
Fares Zahir was appointed Chief Executive Officer (“CEO”) of Xeraya Capital Sdn Bhd in January 2012. He has 20 years of experience in the field of investments in public and private equities. Fares was previously with Khazanah Nasional Bhd, where he headed the Life Sciences Unit that formulates investment strategies, and undertakes and monitors the organization's Life Sciences investments, and also headed Khazanah's Research Unit that undertakes research work in the areas of financial capital markets, industrial organization and economics.

Fares co-founded Xeraya Capital during his tenure in Khazanah together with other team members who collectively provided key input to the Government of Malaysia on incentivizing the Malaysian private sector to invest in risk capital.

Fares has been Co-Chairman of the Malaysian Life Sciences Capital Fund (“MLSCF”) since July 2008, a fund that is globally recognized in the biogreentech space. He has been a Board member of the Malaysian Technology Development Corporation (“MTDC”) and Spring Hill Bioventures from October 2005 and March 2008 respectively, and was appointed to the Board of the Malaysian Biotechnology Corporation (“Biotech Corp”) in December 2011. In addition, he sits on the Board of investee companies in the US and in Malaysia.

From 1999 to 2005, Fares was Director, Investment Research at UBS Investment Bank where he was a key member of their top rated Malaysian equity research team. From 1996 to 1999, he was Fund Manager with the Schroder Group (also a JV company of the PNB Group) where he managed the Schroder Group's institutional clients' portfolios after serving as an investment analyst from 1994-1996 making investment recommendations to the Schroder Group's portfolio managers worldwide. Fares started his career in Malaysia in the actuarial department of American International Assurance Co. Ltd. in Kuala Lumpur where he worked from 1992 to 1994.

Fares holds a Bachelor of Economics degree in Actuarial Studies from Macquarie University in Australia where he graduated in 1990 and a Master of Applied Science in Operations Research from University Technology Sydney in 1992. He is also a Chartered Financial Analyst (“CFA”) and an Associate of the Society of Actuaries (“ASA”) of North America.
Investments
Aditya Puri
Investment Partner
Aditya Puri is an Investment Partner at Xeraya Capital; he joined the company in October 2012.

Previously, he was a Director in Khazanah Nasional's Life Sciences unit, which was responsible for Khazanah's Life Sciences investments. He has almost 20 years of experience and leadership in new ventures, corporate investing, and international expansion in life science and technology industries.

Prior to Khazanah, Aditya was in the greater Boston area working with Healthcare and Cleantech startups affiliated with Harvard and MIT. He evaluated new technologies and partnered with inventors at high potential startups, and consulted on growth, customer acquisition, and commercialization strategies. He was also part of the leadership team at Yankee Group, a global technology research and consulting company, where he launched and had full P&L responsibility for a multimillion dollar global licensing and subscription business. He joined them as a consultant covering Asia Pacific, and advised clients on market entry, due diligence, and investment related decisions.

At Boston Scientific, a Fortune 500 medical device manufacturer, Aditya was part of a five-member team reporting to the CFO chartered with the company's inorganic growth and corporate development activity. In this role he identified and closed new investment opportunities, and was instrumental in deals that have, in addition to high returns, resulted in significant long-term value for the company. He began his career at KPMG.

Aditya has a B.S. from the University of Southern Maine, graduating Summa Cum Laude, and received his MBA from the MIT Sloan School of Management. He has also passed all parts of the U.S. Uniform CPA Examination.
Jason Rushton
Investment Partner
Jason brings with him a wealth of life science experience with strong business networks especially in Europe. He is an accomplished life sciences practitioner with over two decades of experience in various areas in the sector including drug development, drug discovery, management consulting, venture capital, strategy consulting and corporate finance advisory.

Jason joined Xeraya Capital from Deloitte, Geneva, Switzerland where for five years he was Director, Corporate Finance Advisory, leading the firm's healthcare and life science advisory (M&A) business. Before joining Deloitte he spent a short period as a independent strategy consultant.

His working career in the venture capital industry began with the Merlin Biosciences Fund and later with the Inventages (Nestle) Fund where he sourced, evaluated and closed numerous venture capital investments and was involved in post investment management of portfolio companies including taking on Board positions. Prior to that Jason was a management consultant in the life science group of PA Consulting. His early career was in the sciences, initially in drug development with Medeva Group and Cortecs Ltd, and later in drug discovery with Eli Lilly.

Jason holds a Master of Science degree in Immunology, and a Bachelor of a Science (Hons) degree in Anatomy, both from the University of Birmingham, UK.
Lim Su San
Investments Senior Vice President
Susan joined Xeraya Capital as an Investments Senior Vice President in October 2012. She was previously SVP at Khazanah Research & Investment Strategy (KRIS)'s Life Sciences Unit, which formulates investment strategies, and undertakes and monitors the organisation's Life Sciences investments.

As part of the Life Sciences Unit's founding team, Susan was a key element in the various achievements of the group. She has been deeply involved in all the direct and indirect investments, and at various times has led or managed critical facets of the investment process - opportunity assessment, valuation, selection and oversight of external advisors - to name a few. She is also credited with streamlining the various internal processes to consummate investments at Khazanah, including building the framework and relationships with all the necessary constituents. One of her primary ongoing responsibilities includes the performance monitoring of the Life Sciences Unit's global investment portfolio.

Susan has more than 10 years of experience in the finance and investment fields. She joined Khazanah in September 2005 from Malaysian Rating Corporation Berhad (MARC), where she was a member of the Internal Rating Committee. The group was responsible for ratings related to project finance and corporate debts in various sectors, including infrastructure, conglomerates, utilities, and oil and gas related companies. Prior to joining MARC, she was a Credit Review Officer at AmMerchant Bank Berhad.

Susan holds a Bachelor of Business degree, with a major in Economics and Finance, from RMIT University, Melbourne, Australia. She is also a Chartered Financial Analyst (CFA) charterholder.
Norazli bin Mohamad Nor
Investments Senior Vice President
Norazli bin Mohamad Nor joined Xeraya Capital as a Vice President from Khazanah in October 2012. He has over 17 years of career experience that includes investment, consulting and execution. He has expertise in corporate strategies, finance and operations with a delivery record relating to acquisition, restructuring, operational turnaround and large-scale engineering delivery.

In 2008, Norazli joined Khazanah Nasional as a Vice President. In that role, he has assessed investment pipeline deals and startups, whilst overseeing a portfolio comprising of over 20 technology companies. He was deeply involved in the preparatory aspects and the inception of both Xeraya Capital and the Mudharabah Innovation Fund.

Before Khazanah, Norazli was an Associate Director at KPMG's consulting practice, focusing primarily in infrastructure development, particularly public-private partnerships and private finance initiatives. Between 1995 and 2007 he worked at Tenaga Nasional Berhad in various technical and management consulting leadership roles.

He was registered as a Professional Engineer with the Board of Engineers Malaysia. Azli holds a Bachelor of Engineering (Electrical and Electronics) from Imperial College, London, United Kingdom, and an MBA in Finance from International Islamic University Malaysia.
Goh Wei Ling
Investments Senior Vice President
Wei Ling joined Xeraya in December 2013 as VP, Investments. She carries with her over 10 years of private equity experience, which included frontline investment work, fund management and fund raising activities. Wei Ling also brings to Xeraya extensive experience in conducting corporate due diligence, deal execution, portfolio monitoring including sitting on Boards of investee companies and stakeholder management. She was previously with CDC Group plc and Actis Capital (following the de-merger from CDC) working as the Accountant based in Malaysia. She subsequently moved on to doing full time investment with Aureos Capital/The Abraaj Group.

She started her career with KPMG as an auditor. She was also involved in financial due diligence assignments and corporate restructuring exercises.

Wei Ling is an Australian CPA and a Malaysian Chartered Accountant. She holds a Bachelor of Business (Accountancy) degree with distinction from RMIT University Australia.
Rohit Pratap Singh
Investments Assistant Vice President
Rohit joined Xeraya Capital as an Assistant Vice President in August 2015. He has over 10 years of career experience that includes investment banking and VC investments.

Rohit has extensive experience in the M&A/ VC space. As an investment banker, he has represented clients from Asia, Europe and USA in advising them in cross border acquisitions worth > USD 1 bn and as a VC he has been part of investments in U.S and Asia. Apart from developing skill sets in equity transactions, Rohit also brings in a cross cultural work experience gained working in different regions, jurisdictions, understanding of local/ international M&A laws and developing an extensive network of bankers and fund managers.

Prior to Xeraya, Rohit has worked in PwC, KPMG and Rabobank in their respective M&A/ Corporate Finance transaction teams. Rohit graduated as an engineer and has an MBA from India’s leading institution- Indian Institute of Technology, Kharagpur. He is also a Chartered Financial Analyst (“CFA”) charterholder.
Noorhayati M. Nasir
Investments Assistant Vice President
Noorhayati M. Nasir joined Xeraya Capital as an Assistant Vice President Investments in August 2016. Prior to Xeraya, she was Vice President Business Development and Investment Healthcare at Malaysian Biotechnology Corporation Sdn Bhd (BiotechCorp).

Noorhayati has 10 years of experience working on investments in Life Science specifically Healthcare sector, with primary concerns on economic development initiatives. She was responsible in assessing business proposals for grant and incentive applications, advising and facilitating investors in due diligence, business model structuring, business matching, government relations and project implementation. As part of the pioneer team in Healthcare Business Development and Investment unit, she successfully supported multiple investments into Malaysia in various subsectors under Healthcare.

Noorhayati was heavily involved in creating linkages between international companies and local universities to promote industry-academia partnership, fostering innovation and commercialization.

Whilst at BiotechCorp, Noorhayati was part of various policy development roundtable discussions and was appointed as the Core Team Member for the Horizon Scanning Committee under the Health Technology Assessment Unit in Ministry of Health (MOH) Malaysia, offering technical advise on new and emerging health technologies.

Noorhayati holds a Bachelor of Science Degree majoring in Biotechnology from University Malaya and an MBA in International Business from University Putra Malaysia.
Shafini Abd Hapiz
Associate, Investments
Shafini Abd Hapiz joined Xeraya Capital as an Associate, Investments in October 2012. Shafini has a diverse background in biotechnology and business. Before Xeraya, Shafini was an analyst intern in the corporate finance and investment banking group for Deutsche Bank in Singapore and London. In that role, she specialized in the chemical industry, developing and mining financial data to forecast revenue, and identifying future trends and risks. She was integral in the due diligence of several chemical companies in preparation for M&A and public offerings.

Before Deutsche Bank, she was a business development trainee at CellFacts Instruments Ltd in the UK. She developed market research and analysis on possible new industries for the firm to enter and worked with senior management on improving the company's sales and marketing execution. Previously, she was a patent executive trainee at Patrick Mirandah & Co. Bhd in Kuala Lumpur and held a summer internship at Environmental Biotechnology CRC in Sydney, Australia.

Shafini holds a Bachelor of Science degree (with first-class honours) in biotechnology from the University of New South Wales in Australia, and a Master of Science degree (with distinction) in biotechnology, bioprocessing and business management from the University of Warwick in the UK.
Siti Zafirah Bt Azmi
Associate, Investments
Zafirah Azmi joined us as an Associate, Investments for Xeraya Capital in January 2013. Previously, she had a business internship at Khazanah Nasional, where she focused on research and investment strategy. Zafirah graduated from the Universiti of Malaya with a Master of Science in Research (Plant Biotechnology) and has a Bachelor (Hons) in Industrial Biotechnology from the Universiti Selangor, where she was on the Dean's List.

In 2011, Zafirah was chosen to present a paper at the International Society for Horticultural Science In vitro & Horticultural Breeding Symposium in Ghent, Belgium. In addition, she was a delegate to Youth Defined: Shape Our Future Program National Level conference in 2011 and the Biomalaysia conference in 2010 and 2011. In 2012, she was author of two ISI-cited papers published on Punica granatum.
Nor Na'illah Bt Ahmad Satar
Investments Analyst
Na'illah Satar joined Xeraya as an Analyst in January 2015. After graduation, she had a one-year working experience at Khazanah Nasional as an Investment Trainee. She deals primarily with fund management in Africa, greenfield real estate projects, research and financial analysis of investment opportunities in Wellness and various sectors, both locally and abroad.

She also has previous short working stints in Halal food safety, pharmaceuticals and Organizational Development programs.

Na'illah graduated from the Pennsylvania State University in May 2013, with a BSc in Biotechnology, and minors in Business, Liberal Arts and Microbiology. She completed the International Baccalaureate ("IB") Diploma Program in May 2009.
Megat Khairul Ismail
Investments Analyst
Megat Khairul joined Xeraya Capital as an Investments Analyst in May 2015.

Prior to Xeraya Capital, he spent over 3 years in corporate finance and investment banking. He was most recently a Senior Analyst at Maybank Investment Bank Berhad where he was involved in the execution and financial due diligence of various corporate exercises, which include Initial Public Offerings, Acquisitions, Disposals and Privatisations.

He started his career with ECM Libra Investment Bank as an Investment Banking Analyst and was involved in deal originations in the equity and debt markets along with placements exercises of public listed entities in Malaysia.

Megat Khairul holds a Bachelor of Science degree (Hons) in Finance and Investment Banking from the University of Reading, United Kingdom.
Adrian Wong
Analyst
Adrian joined Xeraya Capital as an Investment Analyst in July 2016. Before Xeraya Capital, Adrian was attached to Maybank Investment Bank for over two and a half years, where he was involved in the origination, structuring and execution of various investment banking and corporate finance mandates covering, amongst others, initial public offerings, mergers & acquisitions, corporate restructurings and independent dvisory services.

Prior to joining the investment banking industry, Adrian has over a year of private/ venture equity experience in Westhill Equity, which included experience in investment and financial appraisals, due diligence, preparation of periodic investment reports as well as portfolio monitoring and management.

Adrian holds a Bachelor of Science degree (with first-class honours) in Accounting and Finance from Lancaster University, United Kingdom. He is currently pursuing his ACCA qualifications.
Corporate
Alan Cheah
Chief Financial Officer
Alan Cheah is Chief Financial Officer for Xeraya Capital since May 2012. He has more than 15 years of audit, transaction advisory, corporate finance and risk management experience that includes international exposure. Before Xeraya, Alan was a senior manager for financial services and asset management with Ernst & Young FSO in Bermuda, Bahamas, British Virgin Islands, Cayman Islands and New York.

At EY, Alan managed the entire audit process and advisory services for a portfolio of clients within the asset management industry specialising in hedge funds, private equity firms, mutual funds, investment management companies and fund administrators. He was actively involved with EY's internal and external valuation teams in the valuation of private companies across various industries.

Before EY, Alan worked for KPMG in Shanghai and Hong Kong, where he managed a portfolio of clients within the manufacturing, infrastructure, technologies and telecommunications and services industry.

Previously, Alan worked as a business and risk controller for IKEA in Kuala Lumpur and Singapore, and for EY in Malaysia as an assistant manager in the company's assurance and business advisory practice.

Alan has a Bachelor of Accounting (Hons) from Northern University of Malaysia, is a Certified Public Accountant from Malaysian Institute of Certified Public Accountants, and is a Chartered Accountant - Malaysian Institute of Accountants.
Norashikin Muhamad
Head of Legal and Company Secretary
Norashikin Muhamad is head of legal and compliance for Xeraya Capital from January 2013. Before Xeraya, Norashikin was general manager for corporate services and legal at Senai Airport Terminal Services in Johor, Malaysia. In that role, she provided legal advisory services on local and international activities, such as incorporations, mergers and acquisitions, commercial loans, and issuance of Islamic Medium Term Notes. She was also responsible for the smooth operation of board and committee meetings, ensuring both were planned and executed carefully.

In addition, she oversaw the provision of effective and efficient secretarial services to the board, the board committees, the executive committee, and management committee. Norashikin also was responsible for corporate compliance, including filing statutory forms and ensuring the company followed good corporate governance and practices.

Before Senai Airport, Norashikin was a legal advisor to Prestico SDN Bhd, where she provided legal advice and support to the entire company. She also spent four years at Southern Bank Berhad as head of credit and documentation.

Norashikin holds and LLB (with honors) from Leeds Metropolitan University in the UK.
Kumaraguru Veerasamy
Head of Strategic Research
Kumar joined Xeraya in January 2014 as the Head of Strategic Research.

Prior to that Kumar was the Strategic Research Head for Sime Darby's Group Strategy and Business Development. Kumar has more than 20 years of working experience ranging from heading the Frost and Sullivan Chemical , Material and Foods division for Asia Pacific to leading techno-commercial business development roles in various global companies including Uniqema – ICI, Glaxo SmithKline Beecham and Felda Procter Gamble (FPG) oleochemicals. Kumar has garnered extensive expertise in the operational sectors, consulting & market research, execution and planning business strategies. He possesses a breadth of thought leadership within the life sciences sector to drive Xeraya's business vision.

Kumar graduated with Chemistry Degree from University Science Malaysia and has a post graduate diploma from Sanno Japanese Institute.
Irene Chen
Vice President, Reporting and Compliance
Irene joined Xeraya in October 2013. Irene has over 10 years of working experience that includes transaction advisory, regulatory and external audit experience with international exposure in Bermuda.

Prior to joining Xeraya, she was a senior manager with Baker Tilly. In that role, she handles and manages special reporting assignments on due diligence audits for Initial Public Offerings, corporate restructuring exercises, due diligence for mergers and acquisitions and various corporate exercises.

Before Baker Tilly, Irene worked as a Senior Analyst for the Bermuda Monetary Authority in Bermuda specialising in risks and compliance of investment fund companies and registered fund administrators.

Previously, Irene worked for PricewaterhouseCoopers in Bermuda and Ernst & Young, Malaysia where she managed the external audit process for a broad range of clients within the financial services, retail and commercial, property, construction and plantation industry.

She is a Certified Practicing Accountant of CPA, Australia and a member of the Malaysian Institute of Accountants and holds a Degree in Bachelor of Business and Commerce with a double major in Accounting and Finance from Monash University.
Lawrence Khoo
Associate, Strategic Research
Lawrence joined Xeraya Capital in March 2016 as an Associate with over 4 years of experience in corporate strategy, business development and venture-type transactions.

He was previously a Senior Executive with Sime Darby Renewables, a new unit which he helped set-up to drive investments in breakthrough technologies for Sime Darby Plantation. Apart from transaction experiences covering due diligence, execution and monitoring, he was also actively involved in supporting business development initiatives of the portfolio companies.

He started his career in Sime Darby’s Group Strategy & Business Development, where he was principally involved in developing strategic blueprints to guide the Group’s overall business direction.

Lawrence holds a Bachelor of Science in Biotechnology from Universiti Putra Malaysia, graduating with First Class Honours. He is currently a Level III candidate in the CFA Program and is a past Sime Darby scholar.
Syaron Tang
Analyst, Finance
Syaron Tang joined Xeraya as an Analyst, Finance in January 2016.

Prior to Xeraya, she assumed the role of Senior Accounts Associate at Niche & Milestones International Sdn Bhd. At Niche, she was an outsourced accountant for a number of SMEs of different industries, which includes trading, advertising and engineering services in F&B where she manages and monitors the companies’ accounts and reporting systems. She also prepares full sets of management accounts for clients with GST compliance.

Syaron Tang graduated from HELP University in October 2013, with a Bachelor of Business (Hons) Accounting. She is currently pursuing her ACCA.
Jessie Lim
Office Manager
As Xeraya's Office Manager since May 2012, Jessie is responsible for all the administrative tasks and day-to-day core working of the company. She is the proverbial "glue" that holds the moving parts of the organization together, and ensures that the many activities work together cohesively.

Jessie's previous work experience is varied, and lends itself well to Xeraya's multi-faceted mandates. Prior to Xeraya, she was involved in real-estate, negotiating complex transactions involving condominiums, residential and commercial properties, and land parcels. At Matrix Connexion, one of Google's major resellers in Malaysia, she worked closely with the CEO in developing and acquiring corporate clients for Google Apps. In addition to sales and business development activities, Jessie was also responsible for overseeing training, support, and billing and revenue collection functions. Other roles have also encompassed starting and running a small business around Montessori education, retail and event management, and leisure and corporate travel.

In addition to formal education in Economics, Marketing and Early Childhood Education, Jessie also has professional accreditation in Alternative Healing Techniques, including Aromatherapy.
Members of Xeraya's MIF Committee
Shariah Advisory Panel
advises MIF Committee for structuring of Shariah-compliant investments
Datuk Puteh Rukiah
Chairperson, MIF Committee
Datuk Puteh is Chairman of Xeraya's MIF Committee. She is a highly respected individual who understands the intricacies of government after many years of an illustrious career holding key government positions. Even after retirement from the Malaysian civil service, she continues to contribute her experience actively whilst holding to heart the core value of nation building.

Datuk Puteh was formerly Deputy Secretary General (Systems and Controls), at the Ministry of Finance. Prior to that, she held various posts in the Government which among others includes the Undersecretary (Investment, Privatisation and Public Enterprise Division), at the Ministry of Finance. Datuk Puteh currently sits on the boards of Bursa Malaysia Berhad, Pelaburan Hartanah Berhad, Fabtronic Sdn Bhd and Gas Malaysia Berhad and holds a Bachelor of Economics (Honours) degree from University of Malaya and a Master of Economics from Western Michigan University, United States of America.
Mudharabah Innovation Fund
Prof. Dr. Zainul Fadziruddin bin Zainuddin
Member, MIF Committee
Prof. Zainul is Xeraya Board's representative to the MIF Committee. Prof. Zainul is currently Director of Advisory, Incubation and Nurturing at the Malaysian Technology Development Corporation. He was previously the Director of Innovation Office of University Science Malaysia, where he worked toward developing an internal innovation ecosystem to support discovery, creativity, collaboration, intellectual property creation and commercialization of research output of USM. From 1994-1999, he served as the Head, Medical Microbiology & Parasitology Department in the School of Medical Sciences. From 1999-2007, he was founding Dean of the School of Health Sciences.

In addition to an academic career, Prof. Zainul was an MTDC Board member from 2004 until early 2012 and chaired the Investment Committee of MTDC, which has seen close to 500 deal opportunities since 2006. He also gained deep industrial experience as a Senior Vice President in the Malaysian Biotechnology Corporation (BiotechCorp) in 2006, as well as serving on the boards of BiotechCorp, InnovationXchange Malaysia and Sanggar Sains.

Prof. Zainul holds a Bachelor of Science in Microbiology from University of East Anglia, United Kingdom and a Ph.D. in Molecular Microbiology from University of Surrey, United Kingdom.
Mudharabah Innovation Fund
Tn Hj Mohd Radzi Hussein
Member, MIF Committee
Tn Haji Mohd Radzi Hussein is a member of Xeraya's MIF committee.

Mohd Radzi started his career with the Ministry of International Trade and Industry as a cost accountant. Subsequently, he held other various positions in Universiti Utara Malaysia, the Kedah State Treasury, Kedah Akuakultur Sdn Bhd and the Ministry of Home Affairs before he retired as the Director of the Information Technology Management Division, Accountant General Department in 2011.

He was appointed to the Board of the Directors of PAAB in September 2007 as an Independent Director and he is also a Board member of Malaysian Biotechnology Corporation Sdn Berhad.

He holds a Master in Business Administration (MBA) from University of Wales, Aberystwyth, Wales, UK and a Bachelor in Accounting (Hons) from University of Malaya.
Mudharabah Innovation Fund
Dr. Aznan Hasan
Chairman, Shariah Advisory Panel
Dr. Aznan Hasan is an Associate Professor in Islamic law and the former Head of Islamic Law Department, Ahmad Ibrahim Kulliyyah of Laws, International Islamic University Malaysia. He is currently the President, Association of Shariah Advisors in Islamic Finance (ASAS). He is also the Deputy Chairman, Shariah Advisory Council, Securities Commission. He was a member, Shariah Advisory Council of Bank Negara Malaysia for two terms (2006-2008, 2010-2013). Prior to joining SAC of Bank Negara Malaysia, he was the Chairman, Shariah Advisory Board, ACR Retakaful MEA, Bahrain ad SEA, Malaysia, where he was instrumental in the setting up of ACR Retakaful Model from Shariah point of view. Currently, he is also the Chairman, Shariah Advisory Board, Barclays Capital (DIFC, Dubai), a member, Shariah Advisory Board, ABSA Islamic Bank (South Africa), FNB Bank (South Africa), European International Islamic Bank (EIIB) (London) Yasaar Limited (London), Khalij Islamic (London), Amanahraya Berhad, Amanah Raya Investment Bank Labuan, Employee Provident Fund (EPF) and some other financial institutions and corporate bodies at both local and international level. He also serves as Shariah consultant to Maybank Investment Bank and Hong Leong Islamic Bank. He is a registered Shariah Advisor for the Islamic Unit Trust Schemes and Islamic securities (Sukuk), Securities Commission of Malaysia. He is also a Member, Shariah Supervisory Board and Investment Committee, Waqaf Foundation, a corporate entity formed by the Government to oversee the application of Waqaf in Malaysia.

Dr. Aznan Hasan received his first Degree in Shariah from University of al-Azhar. He then successfully completed his Masters degree in Shariah from Cairo University with distinction (mumtaz). He then obtained his Ph. D from University of Wales, Lampeter, United Kingdom.

Dr Aznan was involved in many firsts in the structuring of various Islamic financial products, including banking products, capital market products and takaful products and is a recognized thought leader in the sector.
Prof Dr Engku Rabiah Adawiah Binti Engku Ali
Member, Shariah Advisory Panel
Dr Engku Rabiah Adawiah is currently a Professor at IIUM Institute of Islamic Banking and Finance (IIiBF), International Islamic University Malaysia (IIUM). She obtained her LLB (first class honours) and LLB (Shari'ah) (first class honours) from the IIUM. Shortly thereafter, she successfully completed her Masters of Comparative Laws (MCL) from the same university. In 1998, she was conferred with PhD in law from the University of Aberdeen, United Kingdom. She used to teach both Shari'ah and civil law; particularly on the subjects of company law, Islamic banking and finance, and Islamic capital market at both undergraduate and postgraduate levels.

She teaches Islamic capital market, Transactions in Islamic Banking and Finance, Takaful and Retakaful and Contemporary Issues in Islamic Finance for post-graduate students at IIiBF. Her research interest is in Islamic capital market, Islamic banking and finance, Islamic insurance or takaful, Islamic law of transaction, company law and securities regulation. Her publications include books, articles in local and international journals and periodicals; and chapters in books and proceedings. She has presented in various conferences, seminars, workshops and in-house trainings on Islamic Banking, Finance and Capital Market.

She had also served as a member of Shari'ah Committee to a number of financial institutions in the past. Currently, she is a member of the Syariah Advisory Council of Bank Negara Malaysia (Central Bank of Malaysia), Malaysian Securities Commision and Labuan Financial Services Authority (Labuan FSA), and an independent Shari'ah Advisor for Islamic securities (sukuk) issuance, approved by and registered with the Malaysian Securities Commission. In addition, she is also a member of the Shari`ah Board of Labuan Re and Amanah Ikhtiar Malaysia, the Shari`ah advisor for Danajamin (2009 – 2010), a member of the Board of Directors in the Malaysian Institute of Islamic Understanding and a member of the disciplinary committee for the Malaysian Bar Council. She is also a member of the Shari`ah Board to Khazanah in relation to two of its exchangeable sukuk that had been issued by Rafflesia Capital Ltd and Cherating Capital Ltd.
Wan Marhaini Wan Ahmad
Member, Shariah Advisory Panel
Wan Marhaini Wan Ahmad is currently a Senior Lecturer at the Department of Banking and Finance, Faculty of Business and Accountancy, University of Malaya.

She has been a member of the Shariah Advisory Board for Bank Muamalat Malaysia Berhad since 2012 and prior to that for EonCap Islamic Bank Berhad in 2011. She is also a registered Shariah Advisor for the Malaysian Islamic Capital Market and currently a member of the Shariah Advisory Board for Muamalat Invest Sendirian Berhad (2013-2016).

She has received secondary school education from Maahad Muhammadi lil Banat in Kelantan. She obtained her B.Syariah (Hon.) from the University of Malaya, M.Econs. from the International Islamic University Malaysia and Ph.D from the University of Edinburgh, Scotland.
Datuk Dr Hapiz Abdullah
Advisor
Datuk Dr Hapiz bin Abdullah has officially joined Xeraya as an Advisor effective 1st February 2015.

Datuk Hapiz brings with him a wealth of Chemical Industry experience with strong business network especially in the Asia Pacific region. He is an accomplished leader with more than 30 years of Management, Technical, Marketing and Business Development experience in the Chemical industry.

He retired from his last executive role as the President/CEO of Petronas Chemicals Group Berhad ("PCG"). PCG was then a newly listed downstream chemicals company that comprises the consolidation of 20 Petronas fully owned and JV downstream manufacturing and marketing companies. Prior to joining PCG, he spent over 26 years working with multi-national companies ("MNCs") specifically Dupont and Dow Chemicals where his responsibilities evolved from technical, manufacturing, marketing, sales before managing a regional business, during which time he held offices in the USA and Hong Kong.

Datuk Hapiz currently sits on a few Boards namely Petronas Chemical Marketing Labuan Limited ("PCMLL")), Petronas Chemical Marketing ("PCM") and BiotechCorp Malaysia, and is also the Chairman of the Chemical Industry Council of Malaysia ("CICM"), an association that comprises of most of the chemical companies in Malaysia (over 200 companies).

Datuk Hapiz holds a PhD in Organic Chemistry from Utah State University, USA.
Dato' Hans Peter Brenner
Advisor
Dato' Hans brings with him a wealth of medical device, orthopaedic manufacturing and venture partnering experience with strong business networks especially in the Asia Pacific region. He is an accomplished leader with more than 25 years of Management, Marketing and Business Development experience in the Medical Device industry.

Dato' Hans is presently running a firm based in Penang running various consulting, sales and marketing projects in medical devices throughout the Asia-Pacific region. He is also the founder and director of two Malaysian-based firms undertaking contract manufacturing for medical devices, and is a venture partner in a Private Equity firm based in Singapore. He also serves as an independent Board member of Small Bone Innovations Asia Pacific Sdn Bhd.

Prior to that, Dato' Hans was the President for B. Braun and Aesculap Malaysia, responsible for the entire Asia-Pacific business as well as sales and marketing in all Asian countries including Japan and China. Part of his responsibility included regional sales, managing four divisions; production across six locations; and 6,500 employees.

Dato' Hans began his career in PWC, Germany in 1987 and then joined Aesculap in 1990, and B. Braun in 1998.

Dato' Hans holds a Master's Degree in Economy from the University Stuttgart-Hohenheim, Germany.
Bruce Cohen
Advisor
Bruce Cohen has officially joined Xeraya in January 2016.

Bruce brings with him a wealth of business leadership experience in the areas of pharmaceuticals and medical technology, with strong business networks in the United States, where he has spent well over 30 years of Management, Marketing and Business Development experience in life sciences and high technology companies.

He was the founding President and CEO of three early stage biotechnology companies; served as CFO for GeneSoft Pharmaceuticals Inc. prior to its merger with Oscient Pharmaceuticals; held senior positions in business development and marketing at SEQUUS Pharmaceuticals Inc. and in the International, Management Services and Information Technology business units at Baxter International.

Bruce was the President and COO of ViTel International Inc., a privately held, pre-internet electronic messaging company. He also served as a management consultant with Monitor Company, working in the healthcare and high technology sectors. Bruce was a member of the founding team of the Tufts Veterinary School and a Regional Manager of the National Health Professions Placement Network.

More recently, Bruce served as Executive Chairman of Xagenic Inc. from 2012 to 2014. He currently serves as a Board member and Chairman of ViroPro, a public company, and CEO of, MEC Dynamics Corporation, a privately held company, and was instrumental in orchestrating the on-going turnaround of both these companies.

Bruce holds a BA, cum laude (1975) and an MA (1980) from Tufts University; and an MBA, with distinction (1982) from Harvard Business School, Harvard University.